Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0025202
Disease: melanoma
melanoma
0.070 AlteredExpression disease BEFREE IMP1 is frequently overexpressed in melanoma and is associated with a poor prognosis, but the full spectrum of IMP1 target transcripts remains unknown. 30543563 2019
CUI: C0025202
Disease: melanoma
melanoma
0.070 Biomarker disease BEFREE To the best of our knowledge, this is the first study that demonstrates the role of RNA-binding protein IGF2BP1 in EV-mediated promotion of melanoma metastasis and may provide novel avenues for the development of metastatic inhibitors. 30936459 2019
CUI: C0025202
Disease: melanoma
melanoma
0.070 Biomarker disease BEFREE These findings suggest that IGF2BP1 can be a novel therapeutic target for melanoma. 29369405 2018
CUI: C0025202
Disease: melanoma
melanoma
0.070 AlteredExpression disease BEFREE IMP1 is frequently overexpressed in cancer and is strongly correlated with a poor prognosis and reduced survival in melanoma, ovarian, breast, colon, and lung cancer. 28846937 2017
CUI: C0025202
Disease: melanoma
melanoma
0.070 AlteredExpression disease BEFREE We previously reported that malignant melanomas express high levels of the mRNA binding protein coding region determinant binding protein (CRD-BP). 21981993 2012
CUI: C0025202
Disease: melanoma
melanoma
0.070 Biomarker disease BEFREE This work also describes a previously unknown role for CRD-BP in the regulation of melanoma cell invasion and highlights the importance of the hypoxic microenvironment in determining cell fate. 23038779 2012
CUI: C0025202
Disease: melanoma
melanoma
0.070 AlteredExpression disease LHGDN Knockdown of CRD-BP inhibits NF-kappaB activity, induces apoptosis, and suppresses proliferation and tumorigenic properties of melanoma cells. 18454174 2008
CUI: C0025202
Disease: melanoma
melanoma
0.070 AlteredExpression disease BEFREE Here, we show that RNA-binding protein, coding region determinant-binding protein (CRD-BP) (a transcriptional target of Wnt signaling pathway), is highly expressed in primary human malignant melanomas and melanoma cell lines with activated Wnt/beta-catenin signaling pathway. 18454174 2008